Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Determine the safety, tolerability, and maximum tolerated dose (MTD) of IV administered VIP236 as monotherapy in patients with advanced solid tumor cancer
创建时间：
2023-01-15
